BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
DNA fingerprint
,
Fluoxetine
,
rs3825942
,
SLC12A1
,
Coagulation
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Synaptotagmin 1/2
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pons
Cerebellar hemisphere
Thalamus lateral nuclei
Midbrain
Whole brain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Methicillin resistant Staphylococcus aureus infection
Fibrosis of lung
Adverse reaction to drug
Hypoxia of brain
Cerebrovascular disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ICRF 193
Berberine
Prnp protein, mouse
Argon
silybin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Htt
TINCR
APPL1
NUCB2
UBA52
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Liver cancer HEP G2 cells with gene overexpression perturbations
Prostate cancer metastatic tumors with PTEN RB1 TRP53 triple knockout
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Synaptotagmin 1/2
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combined Aerobic Exercise and Cognitive Training in Seniors at Increased Risk for Alzheimer's Diseas…
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ